VIVEX Biologics
PrivateLast Round
Debt
Apr 6, 2017
Total Funding Raised
$23.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VIVEX Biologics operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Debt round in April 2017.
VIVEX Biologics is a regenerative medicine company that develops and delivers innovative allografts for orthopedic, spine, wound care, and pain management applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VIVEX Biologics Comparables
Compare VIVEX Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StimLabs | 87% | |
| Skye Biologics Holdings | 86% | |
| Pinnacle Transplant Technologies | 84% |
For institutional investors. Book with your work email.
VIVEX Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 6, 2017 | ||||
| Series A | Jan 6, 2016 | ||||
| Private Equity | Sep 18, 2013 |
For institutional investors. Book with your work email.
VIVEX Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAM Capital Partners | Private Equity |
| Ellis Capital | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
VIVEX Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VIVEX Biologics's valuation, stock price, and market status.
Is VIVEX Biologics a public or private company?
VIVEX Biologics is a private company.
What is the current stock price of VIVEX Biologics?
VIVEX Biologics is a private company, so its shares have no public market price. Caplight tracks VIVEX Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VIVEX Biologics worth (valuation)?
Valuation information for VIVEX Biologics is not publicly available.
Can I buy VIVEX Biologics stock?
VIVEX Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VIVEX Biologics's last funding round?
VIVEX Biologics's most recent funding round was Debt on April 6, 2017.
Who are the main investors in VIVEX Biologics?
Key investors in VIVEX Biologics include JAM Capital Partners, Ellis Capital.
Will VIVEX Biologics IPO soon?
No public IPO plans have been announced for VIVEX Biologics.
How can I track VIVEX Biologics secondary market activity?
Caplight tracks bids, offers, and trades in VIVEX Biologics's shares on secondary markets.